Closed System Transfer Devices Market is Likely to Witness Steady Growth by 2032

The global Closed System Transfer Devices (CSTDs) Market is projected to witness a substantial growth in the coming years owing to technological advancements in healthcare service delivery. It is estimated to reach US$ 872 Million in 2022 and US$ 3800 Million by 2032, with a compound annual growth rate (CAGR) of 18.1% between 2022 and 2032, according to FMI.

The increasing prevalence of cancer is among the factors driving the growth of the closed system transfer devices market globally. As chemotherapy is the primary treatment for cancer, the use of CSTDs has surged for transferring or administering chemicals, which could pose a health risk to healthcare professionals. The risk of surface contamination during chemotherapy is also high, posing a threat not only to healthcare personnel but also to patients and their caregivers. As a result, the demand for closed system transfer devices has risen, along with the number of cancer patients undergoing chemotherapy.

North America is expected to have the largest market share in the closed system transfer devices market due to the increased awareness of CSTDs among oncologists. Numerous initiatives are being taken by regulatory bodies, such as the US Food and Drug Administration, to ensure patient safety and an increase in approvals for oncology medicines. Additionally, the region has access to advanced technologies, and healthcare professionals such as nurses and pharmacists are well-trained and knowledgeable in handling hazardous pharmaceuticals, contributing to the growth of the market in North America.

Closed System Transfer Devices Market Competition

Some of the most prominent companies in the global Closed System Transfer Devices market are ICU Medical, Inc., Equashield LLC, Becton, Simplivia Healthcare, Dickinson and Company, B. Braun Melsungen AG, Corvida Medical, Yukon Medical, Baxter International Inc., and others.

Simplivia Healthcare purchased a 70% share in NOVAMED, a diagnostic company that develops and manufactures a variety of diagnostic kits to address the growing trends in home care.

Browse Detailed Summary of Research Report@ https://www.futuremarketinsights.com/reports/closed-system-transfer-devices-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more